Psychiatry Research: Neuroimaging
Volume 182, Issue 2 , Pages 152-159 , 30 May 2010

Abnormal cerebellar morphometry in abstinent adolescent marijuana users

  • Krista Lisdahl Medina

      Affiliations

    • Department of Psychology, University of Cincinnati, 401D Dyer Hall, Cincinnati, OH 45221, United States
    • ,
  • Bonnie J. Nagel

      Affiliations

    • Department of Psychiatry, Oregon Health and Science University, Portland, OR 97239, United States
    • ,
  • Susan F. Tapert

      Affiliations

    • Department of Psychiatry, University of California, San Diego, 3350 La Jolla Village Drive (151B), San Diego, CA 92161, United States
    • VA San Diego Healthcare System, San Diego, California, United States
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of California, San Diego, 3350 La Jolla Village Drive (151B), San Diego, CA 92161, United States. Tel.: +1 858 552 8585x2599; fax: +1 858 642 6474.

Received 17 July 2009 ,Revised 29 December 2009 ,Accepted 31 December 2009.

References 

  1. Aasly J, Storsaeter O, Nilsen G, Smevik O, Rinck P. Minor structural brain changes in young drug abusers. Acta Neurologica Scandinavica. 1993;87:210–214
  2. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996;91(11):1585–1614
  3. Allen G, Courchesne E. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. American Journal of Psychiatry. 2003;160(2):262–273
  4. Allen G, McColl R, Barnard H, Ringe WK, Fleckenstein J, Cullum CM. Magnetic resonance imaging of cerebellar-prefrontal and cerebellar-parietal functional connectivity. NeuroImage. 2005;28(1):39–48
  5. Amen DG, Waugh M. High resolution brain SPECT imaging of marijuana smokers with AD/HD. Journal of Psychoactive Drugs. 1998;30(2):209–214
  6. Aytaclar S, Tarter RE, Kirisci L, Lu S. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38(2):172–178
  7. Belue RC, Howlett AC, Westlake TM, Hutchings DE. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicology and Teratology. 1995;17(1):25–30
  8. Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL, et al. The cerebellum in attention-deficit/hyperactivity disorder: a morphometric study. Neurology. 1998;50:1087–1093
  9. Bindukumar B, Mahajan SD, Reynolds JL, Hu Z, Sykes DE, Aalinkeel R, et al. Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Research. 2008;1191:1–11
  10. Block RI, O'Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, Arndt S, et al. Effects of frequent marijuana use on brain tissue volume and composition. NeuroReport. 2000;11:491–496
  11. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Ponto LL, Ghoneim MM, et al. Cerebellar hypoactivity in frequent marijuana users. NeuroReport. 2000;11(4):749–753
  12. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM, et al. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacology, Biochemistry and Behavior. 2002;72:237–250
  13. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59(9):1337–1343
  14. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage. 2005;26(2):480–492
  15. Brown SA, Myers MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): a measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol. 1998;59:427–438
  16. Burns HD, Van Laere K, Sanabria-Bohórquez S, Hamill TG, Bormans G, Eng WS, et al. 18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(23):9800–9805
  17. Bussing R, Grudnik J, Mason D, Wasiak M, Leonard C. ADHD and conduct disorder: an MRI study in a community sample. World Journal of Biological Psychiatry. 2002;3:216–220
  18. Cahalan D, Cisin IH, Crossley HM. American Drinking Practices: A National Study of Drinking Behavior and Attitudes. New Brunswick, NJ: Rutgers Center of Alcohol Studies; 1969;
  19. Carlin AS, Trupin EW. The effect of long-term chronic marijuana use on neuropsychological functioning. International Journal of the Addictions. 1977;12(5):617–624
  20. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002;288(14):1740–1748
  21. Casu MA, Pisu C, Sanna A, Tambaro S, Spada GP, Mongeau R, et al. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study. Brain Research. 2005;1048(1–2):41–47
  22. Chang L, Chronicle EP. Functional imaging studies in cannabis users. Neuroscientist. 2007;13(5):422–432
  23. Chang L, Cloak C, Yakupov R, Ernst T. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. Journal of Neuroimmune Pharmacology. 2006;1:65–76
  24. Childers SR, Breivogel CS. Cannabis and endogenous cannabinoid systems. Drug and Alcohol Dependence. 1998;51(1–2):173–187
  25. Courchesne E, Townsend J, Ashkoomoff NA, Saitoh O, Yeung-Courchesne R, Lincoln AJ, et al. Impairment in shifting attention in autistic and cerebellar patients. Behavioral Neuroscience. 1994;108:848–865
  26. Cox RW. AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research. 1996;29:162–173
  27. Croft RJ, Mackay AJ, Milles ATD. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology. 2001;153:373–379
  28. Dar MS. Cerebellar CB(1) receptor mediation of delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse. Brain Research. 2000;864(2):186–194
  29. De Bellis MD, Narasimhan A, Thatcher DL, Keshavan MS, Soloff P, Clark DB. Prefrontal cortex, thalamus and cerebellar volumes in adolescents and young adults with adolescent onset alcohol use disorders and co-morbid mental disorders. Alcoholism, Clinical and Experimental Research. 2005;29(9):1590–1600
  30. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW. MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology. 1999;21(1):63–68
  31. Delis DC, Kaplan E, Kramer JH. Manual for the Delis–Kaplan Executive Function System (D-KEFS). San Antonio, TX: Psychological Corp; 2001;
  32. DeSanty KP, Dar MS. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. Pharmacology, Biochemistry and Behavior. 2001;69(1–2):251–259
  33. Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcoholism, Clinical and Experimental Research. 2004;28(12):1849–1860
  34. Egerton A, Brett RR, Pratt JA. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility. Neuropsychopharmacology. 2005;30:1895–1905
  35. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology. 1999;142:295–301
  36. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana—a comparison with pre-drug performance. Neurotoxicology and Teratology. 2005;27(2):231–239
  37. Ghozland S, Aguado F, Espinosa-Parrilla JF, Soriano E, Maldonado R. Spontaneous network activity of cerebellar granule neurons: impairment by in vivo chronic cannabinoid administration. European Journal of Neuroscience. 2002;16(4):641–651
  38. Giedd JN, Snell JW, Lange N, Rajapakse JC, Casey BJ, Kozuch PL, et al. Quantitative magnetic resonance imaging of human brain development: ages 4–18. Cerebral Cortex. 1996;6:551–560
  39. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America. 2004;17:17
  40. Harkany T, Mackie K, Doherty P. Wiring and firing neuronal networks: endocannabinoids take center stage. Current Opinion in Neurobiology. 2008;18(3):338–345
  41. Harkany T, Keimpema E, Barabás K, Mulder J. Endocannabinoid functions controlling neuronal specification during brain development. Molecular and Cellular Endocrinology. 2008;286(1–2 Suppl. 1):S84–S90
  42. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Annals of the New York Academy of Sciences. 1992;654:19–32
  43. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:1932–1936
  44. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience. 1991;11(2):563–583
  45. Herning RI, Better WE, Tate K, Cadet JL. Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data. Annals of the New York Academy of Sciences. 2001;939:413–415
  46. Herning RI, Better WE, Tate K, Cadet JL. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64(3):488–493
  47. Hicks RE, Gualtieri CT, Mayo JP, Perez-Reyes M. Cannabis, atropine, and temporal information processing. Neuropsychobiology. 1984;12(4):229–237
  48. Hill De, Yeo RA, Campbell RA, Hart B, Vigil J, Brooks W. Magnetic resonance imaging correlates of attention-deficit/hyperactivity disorder in children. Neuropsychology. 2003;17:496–506
  49. Hill SY, Muddasani S, Prasad K, Nutche J, Steinhauer SR, Scanlon J, et al. Cerebellar volume in offspring from multiplex alcohol dependence families. Biological Psychiatry. 2007;61(1):41–47
  50. Hollingshead AB. Two-Factor Index of Social Position. New Haven, CT: Yale University Press; 1965;
  51. Iversen L. Cannabis and the brain. Brain. 2003;126:1252–1270
  52. Ivry RB, Keele SW, Diener HC. Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Experimental Brain Research. 1988;73(1):167–180
  53. Jarvis K, DelBello MP, Mills N, Elman I, Strakowski SM, Adler CM. Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. Journal of Child and Adolescent Psychopharmacology. 2008;18(6):557–563
  54. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2007. In: Volume I: Secondary School Students (NIH Publication No. 08-6418A). Bethesda, MD: National Institute on Drug Abuse; 2008;707 pp.
  55. Kelm MK, Criswell HE, Breese GR. Calcium release from presynaptic internal stores is required for ethanol to increase spontaneous gamma-aminobutyric acid release onto cerebellum Purkinje neurons. Journal of Pharmacology and Experimental Therapeutics. 2007;323(1):356–364
  56. Kelm MK, Criswell HE, Breese GR. The role of protein kinase A in the ethanol-induced increase in spontaneous GABA release onto cerebellar Purkinje neurons. Journal of Neurophysiology. 2008;100(6):3417–3428
  57. Lau T, Schloss P. The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. European Journal of Pharmacology. 2008;578(2–3):137–141
  58. Leh SE, Ptito A, Chakravarty MM, Strafella AP. Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study. Neuroscience Letters. 2007;419(2):113–118
  59. Leiner HC, Leiner AL, Dow RS. Cognitive and language functions of the human cerebellum. Trends in Neuroscience. 1993;16:444–447
  60. Lenroot RK, Giedd JN. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neuroscience and Biobehavioral Reviews. 2006;30:718–729
  61. Lieving LM, Lane SD, Cherek DR, Tcheremissine OV. Effects of marijuana on temporal discriminations in humans. Behavioural Pharmacology. 2006;17(2):173–183
  62. Loeber RT, Yurgelun-Todd DA. Human neuroimaging of acute and chronic marijuana use: implications for frontocerebellar dysfunction. Human Psychopharmacology: Clinical & Experimental. 1999;14:291–304
  63. Lucas CP, Zhang H, Fisher PW, Shaffer D, Regier DA, Narrow WE, et al. The DISC Predictive Scales (DPS): efficiently screening for diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40(4):443–449
  64. Luna B, Sweeney JA. Studies of brain and cognitive maturation through childhood and adolescence: a strategy for testing neurodevelopmental hypotheses. Schizophrenia Bulletin. 2001;27(3):443–455
  65. Lyons MJ, Bar JL, Panizzon MS, Toomey R, Eisen S, Xian H, et al. Neuropsychological consequences of regular marijuana use: a twin study. Psychological Medicine. 2004;34:1239–1250
  66. Mackie K. Cannabinoid receptors: where they are and what they do. Journal of Neuroendocrinology. 2008;20(Suppl 1.):10–14
  67. Mackie S, Shaw P, Lenroot R, et al. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. American Journal of Psychiatry. 2007;164:647–655
  68. Mathew RJ, Wilson WH, Turkington TG, Coleman RE. Cerebellar activity and disturbed time sense after THC. Brain Research. 1998;797:183–189
  69. McPartland JM, Glass M, Pertwee RG. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. British Journal of Pharmacology. 2007;152:583–593
  70. Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. Journal of the International Neuropsychological Society. 2007;13:807–820
  71. Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF. Depressive symptoms in adolescents: associations with white matter volume and marijuana use. Journal of Child Psychology and Psychiatry. 2007;48:592–600
  72. Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicology and Teratology. 2007;29:141–152
  73. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addiction Biology. 2009;14(4):457–468
  74. Messinis L, Kyprianidou A, Malefaki S, Papathanasopoulos P. Neuropsychological deficits in long-term frequent cannabis users. Neurology. 2006;66(5):737–739
  75. Mostofsky SH, Reiss AL, Lockhart P, Denckla MB. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. Journal of Child Neurology. 1998;13:434–439
  76. Nagel BJ, Medina KL, Yoshii J, Schweinsburg AD, Moadab I, Tapert SF. Age-related changes in prefrontal white matter volume across adolescence. NeuroReport. 2006;17:1427–1431
  77. Neufang S, Fink GR, Herpertz-Dahlmann B, Willmes K, Konrad K. Developmental changes in neural activation and psychophysiological interaction patterns of brain regions associated with interference control and time perception. NeuroImage. 2008;43(2):399–409
  78. Nigg JT, Glass JM, Wong MM, Poon E, Jester JM, Fitzgerald HE, et al. Neuropsychological executive functioning in children at elevated risk for alcoholism: findings in early adolescence. Journal of Abnormal Psychology. 2004;113(2):302–314
  79. O'Hare ED, Kan E, Yoshii J, Mattson SN, Riley EP, Thompson PM, et al. Mapping cerebellar vermal morphology and cognitive correlates in prenatal alcohol exposure. NeuroReport. 2005;16(12):1285–1290
  80. O'Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL, et al. Acute marijuana effects on rCBF and cognition: a PET study. NeuroReport. 2000;11(17):3835–3841
  81. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, et al. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology. 2002;26(6):802–816
  82. O'Leary DS, Block RI, Turner BM, Koeppel J, Magnotta VA, Ponto LB, et al. Marijuana alters the human cerebellar clock. NeuroReport. 2003;14(8):1145–1151
  83. O'Leary DS, Block RI, Koeppel JA, Schultz SK, Magnotta VA, Ponto LB, et al. Effects of smoking marijuana on focal attention and brain blood flow. Human Psychopharmacology. 2007;22(3):135–148
  84. Patel S, Hillard CJ. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. Journal of Pharmacology and Experimental Therapeutics. 2001;297(2):629–637
  85. Pazos MR, Núñez E, Benito C, Tolón RM, Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacology, Biochemistry and Behavior. 2005;81(2):239–247
  86. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Archives of Neurology. 1994;51:874–887
  87. Piguet O, Cramsie J, Bennette HP, et al. Contributions of age and alcohol consumption to cerebellar integrity, gait and cognition in non-demented very old individuals. European Archives of Psychiatry and Clinical Neuroscience. 2006;256:504–511
  88. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 2004;56:86–94
  89. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association. 1996;275(7):521–527
  90. Pope HG, Jacobs A, Mialet JP, Yurgelun-Todd D, Gruber S. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychotherapy & Psychosomatics. 1997;66:179–184
  91. Quickfall J, Crockford D. Brain neuroimaging in cannabis use: a review. Journal of Neuropsychiatry and Clinical Neurosciences. 2006;18(3):318–332
  92. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, et al. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcoholism, Clinical and Experimental Research. 1995;19:1018–1023
  93. Ridenour TA, Tarter RE, Reynolds M, Mezzich A, Kirisci L, Vanyukov M. Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys. Drug and Alcohol Dependence. 2009;102(1–3):71–77
  94. Robins L, Cottler L, Bucholz K, Compton W. In: The Diagnostic Interview Schedule, Version 4.0. 1996;(DIS 4.0)
  95. Rodríguez de Fonseca F, Del Arco I, Martín-Calderón JL, Gorriti MA, Navarro M. Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiology of Disease. 1998;5(6 Pt B):483–501
  96. Rubia K, Smith AB, Taylor E, Brammer M. Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Human Brain Mapping. 2007;28(11):1163–1177
  97. Schaeffer J, Andrysiak T, Ungerleider JT. Cognition and long-term use of ganja (Cannabis). Science. 1981;213(4506):465–466
  98. Schmahmann JD. The role of the cerebellum in affect and psychosis. Journal of Neurolinguistics. 2000;13:189–214
  99. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561–579
  100. Schmahmann JD, Donyon J, et al. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. NeuroImage. 1999;10:233–260
  101. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, et al. A hybrid approach to the skull stripping problem in MRI. NeuroImage. 2004;22:1060–1075
  102. Skosnik PD, Edwards CR, O'Donnell BF, Steffen A, Steinmetz JE, Hetrick WP. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology. 2008;33(6):1432–1440
  103. Sneider JT, Pope HG, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA. Altered regional blood volume in chronic cannabis smokers. Experimental and Clinical Psychopharmacology. 2006;14(4):422–428
  104. Sneider JT, Pope HG, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA. Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. European Neuropsychopharmacology. 2008;18(8):612–619
  105. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In:  Raye Z,  Litten JPA editor. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ, US: Humana Press, Inc; 1992;p. 41–72
  106. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association. 2002;287(9):1123–1131
  107. Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal mapping of cortical thickness and brain growth in normal children. Journal of Neuroscience. 2004;24:8223–8231
  108. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164–1178
  109. Stewart DG, Brown SA. Withdrawal and dependency symptoms among adolescent alcohol and drug abusers. Addiction. 1995;90:627–635
  110. Suárez J, Bermúdez-Silva FJ, Mackie K, Ledent C, Zimmer A, Cravatt BF, et al. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. Journal of Comparative Neurology. 2008;509(4):400–421
  111. Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke–Korsakoff syndrome. Alcohol and Alcoholism. 2009;44(2):155–165
  112. Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, et al. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berlin). 2007;194:173–183
  113. Timmann D, Drepper J, Maschke M, Kolb FP, Böring D, Thilmann AF, et al. Motor deficits cannot explain impaired cognitive associative learning in cerebellar patients. Neuropsychologia. 2002;40(7):788–800
  114. Varma VK, Malhotra AK, Dang R, Das K, Nehra R. Cannabis and cognitive functions: a prospective study. Drug and Alcohol Dependence. 1988;21(2):147–152
  115. Viveros MP, Llorente R, Moreno E, Marco EM. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behavioural Pharmacology. 2005;16(5–6):353–362
  116. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A, et al. Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Research. 1996;67:29–38
  117. Wadsworth EJ, Moss SC, Simpson SA, Smith AP. Cannabis use, cognitive performance and mood in a sample of workers. Journal of Psychopharmacology. 2006;20(1):14–23
  118. Wallace GL, Eric Schmitt J, Lenroot R, Viding E, Ordaz S, Rosenthal MA, et al. A pediatric twin study of brain morphometry. Journal of Child Psychology and Psychiatry. 2006;47(10):987–993
  119. Whitlow CT, Liguori A, Livengood LB, Hart SL, Mussat-Whitlow BJ, Lamborn CM, et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug and Alcohol Dependence. 2004;76(1):107–111
  120. Wilkinson GS. The Wide Range Achievement Test-3 Administration Manual. Wilmington, DE: Jastak Associates; 1993;
  121. Wong EC, Luh WM, Buxton RB, Frank RL. Single slab high resolution 3D whole brain imaging using spiral FSE. Proceedings of the International Society of Magnetic Resonance Medicine. 2000;8:683
  122. Yamasaki M, Hashimoto K, Kano M. Miniature synaptic events elicited by presynaptic Ca2 rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells. Journal of Neuroscience. 2006;26:86–95
  123. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, et al. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. Journal of Neuroscience. 2006;26:4740–4751

PII: S0925-4927(10)00002-8

doi: 10.1016/j.pscychresns.2009.12.004

Psychiatry Research: Neuroimaging
Volume 182, Issue 2 , Pages 152-159 , 30 May 2010

Article Tools

* Image Usage & Resolution